Literature DB >> 7568328

International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. IX. Recommendations on terms and symbols in quantitative pharmacology.

D H Jenkinson1, E A Barnard, D Hoyer, P P Humphrey, P Leff, N P Shankley.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 7568328

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  31 in total

1.  Functional characterization of rat submaxillary gland muscarinic receptors using microphysiometry.

Authors:  T D Meloy; D V Daniels; S S Hegde; R M Eglen; A P Ford
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens.

Authors:  R Bigoni; G Calo; R Guerrini; J W Strupish; D J Rowbotham; D G Lambert
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

3.  Effects of castration on contraction and alpha(1)-adrenoceptor expression in rat prostate.

Authors:  Y Homma; K Hamada; Y Nakayama; G Tsujimoto; K Kawabe
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

4.  Pharmacological characterization of prostanoid receptors mediating vasoconstriction in human umbilical vein.

Authors:  Federico Manuel Daray; Ana Itatí Minvielle; Soledad Puppo; Rodolfo Pedro Rothlin
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

5.  Increased alphaCGRP potency and CGRP-receptor antagonist affinity in isolated hypoxic porcine intramyocardial arteries.

Authors:  Philip Hasbak; Karen Eskesen; Søren Schifter; Lars Edvinsson
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

6.  Selective and functional 5-hydroxytryptamine4 receptor antagonism by SB 207266.

Authors:  K A Wardle; S Bingham; E S Ellis; L M Gaster; B Rushant; M I Smith; G J Sanger
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

7.  Potent antagonism by BIM-23056 at the human recombinant somatostatin sst5 receptor.

Authors:  G F Wilkinson; R J Thurlow; L A Sellers; J E Coote; W Feniuk; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

8.  Involvement of endothelial thromboxane A2 in the vasoconstrictor response induced by 15-E2t-isoprostane in isolated human umbilical vein.

Authors:  Federico Manuel Daray; Julia Renata Colombo; Julián Rodríguez Kibrik; Andrea Emilse Errasti; Facundo Germán Pelorosso; Wanda Nowak; Jean-Luc Cracowski; Rodolfo Pedro Rothlin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08       Impact factor: 3.000

9.  Pharmacological characterization of the novel nociceptin/orphanin FQ receptor ligand, ZP120: in vitro and in vivo studies in mice.

Authors:  Anna Rizzi; Daniela Rizzi; Giuliano Marzola; Domenico Regoli; Bjarne Due Larsen; Jorgen Soberg Petersen; Girolamo Calo'
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

10.  Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro.

Authors:  Anna Siniscalchi; Donata Rodi; Michele Morari; Matteo Marti; Sabrina Cavallini; Silvia Marino; Lorenzo Beani; Clementina Bianchi
Journal:  Br J Pharmacol       Date:  2002-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.